The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Purpose: This contribution explores the underuse of artificial intelligence (AI) in the health sector, what this means for practice, and how much the underuse can cost. Attention is drawn to the relevance of an issue that the European Parliament has outlined as a "major threat" in 2020. At its heart is the risk that research and development on trusted AI systems for medicine and digital health will pile up in lab centers without generating further practical relevance. Our analysis highlights why researchers, practitioners and especially policymakers, should pay attention to this phenomenon. Methods: The paper examines the ways in which governments and public agencies are addressing the underuse of AI. As governments and international organizations often acknowledge the limitations of their own initiatives, the contribution explores the causes of the current issues and suggests ways to improve initiatives for digital health. Results: Recommendations address the development of standards, models of regulatory governance, assessment of the opportunity costs of underuse of technology, and the urgency of the problem. Conclusions: The exponential pace of AI advances and innovations makes the risks of underuse of AI increasingly threatening. Graphical Abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Floridi, L., Cowls, J., Beltrametti, M., Chatila, R., Chazerand, P., Dignum, V., Luetge, C., Madelin, R., Pagallo, U., Rossi, F., et al. (2018) · Minds and Machines · doi:10.1007/s11023-018-9482-5 · Cited by 4,774 · cited 1×
“In addition to threats and menaces of AI in the health sector that depend on misuses or overuses of the technology, the attention should be drawn to possible underuses of AI [10].”
BackgroundSelf-citationRajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579
The potential for artificial intelligence in healthcare
Davenport, T., & Kalakota, R. (2019) · Future Healthcare Journal · doi:10.7861/futurehosp.6-2-94 · Cited by 3,800
Deep learning for healthcare: review, opportunities and challenges
Miotto, R., Wang, F., Wang, S., Jiang, X., & Dudley, J. T. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx044 · Cited by 3,076 · cited 1×
“In this domain, success stories include the use of ML enabling the largest Brain Tumor Study To-Date [85], as well as deep patient studies and derivates [86].”
MethodAn overview of clinical decision support systems: Benefits, risks, and strategies for success
Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., & Kroeker, K. I. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0221-y · Cited by 3,019 · cited 1×
“The scalability of these systems is impeded by challenges such as data interoperability, limited integration with electronic health records (EHRs), and concerns pertaining to liability and accountability [63].”
BackgroundClinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
The practical implementation of artificial intelligence technologies in medicine
He, J., Baxter, S. L., Xu, J., Xu, J., Zhou, X., & Zhang, K. (2019) · Nature Medicine · doi:10.1038/s41591-018-0307-0 · Cited by 2,246
The Brussels Effect: How the European Union Rules the World
Bradford, A. (2020) · doi:10.1093/oso/9780190088583.001.0001 · Cited by 1,349
The ethics of AI in health care: A mapping review
Morley, J., Machado, C. C. V., Burr, C., Cowls, J., Joshi, I., Taddeo, M., & Floridi, L. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113172 · Cited by 1,105
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Mei, X., Lee, H.-C., Diao, K.-Y., Huang, M., Lin, B., Liu, C., Xie, Z., Ma, Y., Robson, P. M., Chung, M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0931-3 · Cited by 1,084
Cited by
Generative artificial intelligence in medicine
Teo, Z. L., Thirunavukarasu, A. J., Elangovan, K., Cheng, H., Moova, P., Soetikno, B., Nielsen, C., Pollreisz, A., Ting, D. S. J., Morris, R. J. T., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03983-2 · Cited by 119
Large Language Models lack essential metacognition for reliable medical reasoning
Griot, M., Hemptinne, C., Vanderdonckt, J., & Yuksel, D. (2025) · Nature Communications · doi:10.1038/s41467-024-55628-6 · Cited by 172
“AI also introduces signi fi cant challenges due to its nature asa probabilisticblack box that often lacks transparency, explicability, and interpretability 20 .”
Patnaik, P., & Bakkar, M. (2024) · Technology in Society · doi:10.1016/j.techsoc.2024.102750 · Cited by 100
Truly risk-based regulation of Artificial Intelligence: how to implement the EU's AI act
Ebers, M. (2025) · European Journal of Risk Regulation · doi:10.1017/err.2024.78 · Cited by 126
Metadata
- Authors
- Pagallo, U., O’Sullivan, S., Nevejans, N., Holzinger, A., Friebe, M., Jeanquartier, F., Jean-Quartier, C., & Miernik, A.
- Venue
- Health and Technology
- Published
- 2023-12-12
- Volume
- 14
- Issue
- 1
- Pages
- 1-14
- ISSN
- 2190-7188 (ISSN-L)
- 2190-7196
- OpenAlex
- W4389622072
- Cited by
- 69
- References
- 24
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations. https://app.cochat.ai/papers/10.1007/s12553-023-00806-7
- The paper
- Pagallo, U., O’Sullivan, S., Nevejans, N., Holzinger, A., Friebe, M., Jeanquartier, F., Jean-Quartier, C., & Miernik, A. (2024). The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations. Health and Technology. https://doi.org/10.1007/s12553-023-00806-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.